Catalyst Watch: AI spotlight at CES, Versant starts trading, and the December jobs report
Source: SeekingAlpha
2026-01-02 15:00:31 ET
More on the markets
- Realistic Expectations For 2026
- Market Rotation Alert: Positioning For A Potentially Tumultuous Year
- S&P 500 And Bitcoin: After 4 Years Of Mediocrity From The Latter, I Own Both, Here's Why
- Steady start to 2026: Few S&P 500 stocks signal overbought or oversold conditions
- Big three ETFs: SPY, VOO, and IVV together attract $200B in 2025
Read the full article on Seeking Alpha
For further details see:
Catalyst Watch: AI spotlight at CES, Versant starts trading, and the December jobs report
RenovoRx Inc.
NASDAQ: RNXT
RNXT Trading
4.72% G/L:
$0.8564 Last:
292,868 Volume:
$0.83 Open:
RNXT Latest News
February 27, 2026 08:30:00 am
RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum
February 26, 2026 08:30:00 am
RenovoRx Announces Acceptance of Clinical Data Abstract at 2026 Society of Interventional Radiology Annual Scientific Meeting
February 05, 2026 08:30:00 am
RenovoRx Appoints Experienced Public Company Executive Mark Voll as Chief Financial Officer
RNXT Stock Data
$36,283,417
33,303,779
2.18%
15
N/A
Biotechnology & Life Sciences
Healthcare
US
Mountain View
